Physician
Massachusetts Eye Research and Surgery Institution, PC
Massachusetts Eye Research and Surgery Institution, PC was paid $78K by Medicaid between Jan 2018 and Oct 2024, across 14 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.
33Billing provider infoMASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION, PC
WALTHAM, MA 02451
WALTHAM, MA 02451
33aNPI1639230527assigned 12/13/2006
33bProvider typeOphthalmology Physician
28Total paid$78K
24GClaims9,254
24DCodes billed14
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Ophthalmology Physician providers in Massachusetts
Rank by total paid#62 of 203
Median peer was paid$18K
This provider vs. median4.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,742 | $9K | |
| 2019 | 592 | $4K | |
| 2020 | 1,013 | $5K | |
| 2021 | 1,511 | $12K | |
| 2022 | 1,814 | $20K | |
| 2023 | 1,449 | $13K | |
| 2024incomplete | 1,133 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 56% | 1,403 | 1,326 | $44K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 27% | 453 | 442 | $21K |
| 92134 | 5.3% | 402 | 321 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 943 | 901 | $3K |
| ATP05 | 1.5% | 399 | 379 | $1K | |
| ATP06 | 1.4% | 351 | 334 | $1K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 14 | 14 | $680.34 |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 41 | 40 | $616.14 |
| 82977 | <1% | 906 | 857 | $544.00 | |
| 84460 | <1% | 928 | 886 | $411.42 | |
| 84450 | <1% | 928 | 886 | $402.78 | |
| 82565 | <1% | 901 | 861 | $394.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEVANS, SCOTT (CEO)
| Provider | Location | Paid |
|---|---|---|
| Grossmont Hospital Corporation | La Mesa, CA | $226.70M |
| Grossmont Hospital Corporation | San Diego, CA | $3.66M |
| Grossmont Hospital Corporation | La Mesa, CA | $21K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.